Takeda will be investing approximately $30 billion into its U.S. operations over the next five years, the company announced.

Gilead Sciences is investing an additional $11 billion into its U.S. operations, the company announced this week, bringing ...

Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 celllines to develop and manufacture AAV ...

ACG Packaging Materials’ greenhouse gas emission reduction targets have been validated by the Science Based Targets ...

Schreiner MediPharm’s new Digital Display Label allows trial sponsors to eliminate time-consuming manual relabeling.

How Praxis Packaging delivers flexible, reliable solutions for pharmaceutical contract packaging needs. As pressures on ...

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

To enhance manufacturing capacity as part of an effort to control complex supply chains and align with U.S. R&D activities.

Bain Capital’s Real Estate team and Botanic Properties, a real estate investment and development firm, have acquired 45 ...

Unlock the full potential of poorly soluble compounds with Spray Dried Dispersions (SDDs). This webinar will explore key ...

ProBioGen has partnered with Polpharma Biologics to conduct high-performance cell line development services for a biosimilar ...

GeneFab, a cell and gene therapy-focused CRDMO, has partnered with RegCell, a biotech company advancing regulatory T cell ...